Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 2, 2011, Pages 241-249

  Fontana, M C ^a,b   Rezer, J F P ^b   Coradini, K ^a   Leal, D B R ^b   Beck, R C R ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; MEMBRANE PROTEIN; NANOCAPSULE; NANOPARTICLE; NICKEL SULFATE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RELEASE; ENZYME ACTIVITY; FEMALE; HYDROGEL; LYMPHOCYTE; NANOEMULSION; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; PH; PHOTON CORRELATION SPECTROSCOPY; RAT; SHEAR RATE; SHEAR STRESS; TREATMENT OUTCOME;

EID: 80054975937     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.05.002     Document Type: Article

References (54)

1. T. Senyigit, C. Padula, Ö. Özer, P. Santi, Different approaches for improving skin accumulation of topical corticosteroids, Int. J. Pharm. 380 (2009) 155-160.
2. U.R. Hengge, T. Ruzicka, R.A. Schwartz, M.J. Cork, Adverse effects of topical glucocorticosteroids, J. Am. Acad. Derm. 54 (2006) 1-15.
3. N.N. Zöller, S. Kippenberger, D. Thaçi, K. Mewes, M. Spiegel, A. Sättler, D. Schultz, J. Bereiter-Hahn, R. Kaufmann, A. Bernd, Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model, Toxicol. In Vitro 22 (2008) 747-759.
4. J.I.T. Capó, X.P. Gutiérrez, C.C. Dominguez, Incremento de la actividad timolítica del clobetasol em forma liposomal, Rev. Cubana Farm. 38 (2004) 2.
5. M. Kalariya, B.K. Padhi, M. Chougule, A. Misra, Clobetasol propionate solid lipid nanoparticles cream for effective treatment if eczema: formulation and clinical implications, Indian J. Exp. Biol. 43 (2005) 233-240. (Pubitemid 40359128)
6. M.L. Marchiori, G. Lubini, G. Dalla Nora, R.B. Friedrich, M.C. Fontana, A.F. Ourique, M.O. Bastos, L.A. Rigo, C.B. Silva, S.B. Tedesco, R.C.R. Beck, Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization and in vitro drug release study, Drug Dev. Ind. Pharm. 36 (2010) 962-971.
7. S.K. Sahoo, S. Parveen, J.J. Panda, The present and future of nanotechnology in human health care, Nanomedicine: N.B.M. 3 (2007) 20-31. (Pubitemid 46428187)
8. M.L. Gordon, The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses, Clin. Ther. 20 (1998) 26-39. (Pubitemid 28126278)
9. S. Wiedersberg, C.S. Leopold, R.H. Guy, Bioavailability and bioequivalence of topical glucocorticoids, Eur. J. Pharm. Biopharm. 68 (2008) 453-466. (Pubitemid 351318206)
10. C. Vauthier, K. Bouchemal, Preparation and manufacture of polymeric nanoparticles, Pharm. Res. 25 (2009) 1025-1058.
11. S.R. Schaffazick, L.L. Freitas, A.R. Pohlmann, S.S. Guterres, Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos, Quim. Nova 25 (2003) 726-737.
12. D. Milão, M.T. Knorst, W. Richter, S.S. Guterres, Hydrophilic gel containing nanocapsules of diclofenac: development, stability study and physic-chemical characterization, Pharmazie 58 (2003) 325-329. (Pubitemid 36604909)
13. M.M. Jiménez, J. Pelletier, M.F. Bobin, M.C. Martini, Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate, Int. J. Pharm. 272 (2004) 45-55. (Pubitemid 38293010)
14. M.P. Alves, A.R. Pohlmann, S.S. Guterres, Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization, Pharmazie 60 (2005) 900-904. (Pubitemid 41820755)
15. M.P. Alves, A.L. Scarrone, M. Santos, A.R. Pohlmann, S.S. Guterres, Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers, Int. J. Pharm. 341 (2007) 215-220. (Pubitemid 47088101)
16. K. Paese, A. Jäger, F.S. Poletto, E.P. Fonseca, B. Rossi-Bergmann, A.R. Pohlmann, S.S. Guterres, Semisolid formulation containing a nanoencapsulated sunscreen: effectiveness, in vitro photostability and immune response, J. Biomed. Nanotechnol. 5 (2009) 240-246.
17. S.S. Guterres, M.P. Alves, A.R. Pohlmann, Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications, Drug Target Insights 2 (2007) 147-157.
18. J. Ladermann, H. Richter, A. Teichmann, N. Otberg, U. Blume-Peytavi, J. Luengo, B. Wei, U.F. Schaefer, C.M. Lehr, R. Wepf, W. Sterry, Nanoparticles - an efficient carrier for drug delivery into the hair follicles, Eur. J. Pharm. Biopharm. 66 (2007) 159-164. (Pubitemid 46654773)
19. G. Rao, R.S.R. Murthy, Evaluation of lipossomal clobetasol propionate topical formulation for intra-dermal delivery, Indian J. Pharm. Sci. 62 (2000) 459-462. (Pubitemid 32422264)
20. T. Senyigit, F. Sonvico, S. Barbieri, Ö. Özer, P. Santi, P. Colombo, Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin, J. Control. Release 142 (2010) 368-373.
21. M. Bonneville, C. Chavagnac, M. Vocanson, A. Rozieres, J. Bebetiere, I. Pernet, A. Denis, J.F. Nicolas, A. Hennino, Skin contact irritation conditions the development and severity of allergic contact dermatitis, J. Invest. Dermatol. 127 (2007) 1430-1435. (Pubitemid 46762985)
22. F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, M.J. Sanz, A. Morelli, M. Torboli, G. Bolignesi, R. Baricordi, Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes, Blood 97 (2001) 587-600.
23. G. Burnstock, G.E. Knight, Cellular distribution and functions of P2 receptor subtypes in different systems, Int. Rev. Cytol. 240 (2004) 301-304.
24. V. Ralevic, G. Burnstock, Involvement of purinergic signaling in cardiovascular diseases, Drug News Perspect. 16 (2003) 133-140. (Pubitemid 37314098)
25. E. Kaczmarek, K. Koziak, J. Sévigny, J.B. Siegel, J. Anrather, A.R. Beaudoin, F.H. Bach, S.C. Robson, Identification and characterization of CD39 vascular ATP diphosphohydrolase, J. Biol. Chem. 271 (1996) 33116-33122. (Pubitemid 27008752)
26. G.S. Kansas, G.S. Wood, G.S. Tedder, Expression, distribution and biochemistry of human CD39: role in activation-associated homotypic adhesion of lymphocytes, J. Immunol. 146 (1991) 2235-2244.
27. K.E. Olson, D. Pulte, M.J. Broekman, A.E. Olson, J. Drosopoulos, N. Islam, E. Musi, A.J. Marcus, CD39/NTPDase1 variants identified in human neutrophils regulate antithrombotic activity, Blood 106 (2005) 11-16.
28. N. Mizumoto, T. Kumamoto, S.C. Robson, J. Sévigny, H. Matsue, K. Enjyoji, A. Takashima, CD39 is dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness, Nat. Med. 8 (2002) 358-865.
29. E.E. Clifford, K.A. Martin, P. Dalal, R. Thomas, G.R. Dubyak, Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-50-nucleotidase in myeloid leukocytes, Am. J. Physiol. 273 (1997) 973-987.
30. R.N. Damle, F. Ghiotto, A. Valetto, E. Albesiano, F. Fais, X.J. Yan, C.P. Sison, S.L. Allen, J. Kolitz, P. Schulman, V.P. Vinciguerra, P. Budde, J. Frey, K.R. Rai, M. Ferrarini, N. Chiorazzi, B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes, Blood 99 (2002) 4087-4093. (Pubitemid 35332051)
31. F. Davi, H.J. Delecluse, P. Guiet, J. Gabarre, A. Fayon, O. Gentilhomme, P. Felman, C. Bayle, F. Berger, J. Audouin, P.A. Bryon, J. Diebold, M. Raphaël, Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus associated non-Hodgkin's lymphomas. Burkitt's lymphoma study group, J. Clin. Oncol. 16 (1998) 3788-3795. (Pubitemid 29001531)
32. H.P. Langston, Y. Ke, A.T. Gewirtz, K.E. Dombrowski, J.A. Kapp, Secretion of IL-2 and IFN-gama, but not IL-4, by antigen-specific T cells requires extracellular, J. Immunol. 170 (2003) 2962-2970. (Pubitemid 36302168)
33. C. Goepfert, M. Imai, S. Brouard, E. Csizmadia, E. Kaczmarek, S.C. Robson, CD39 modulates endothelial cell activation and apoptosis, Mol. Med. 6 (2000) 591-603.
34. M.C. Fontana, K. Coradini, S.S. Guterres, A.R. Pohlmann, R.C.R. Beck, Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system, J. Biomed. Nanotechnol. 5 (2009) 254-263.
35. M.C. Fontana, K. Coradini, S.S. Guterres, A.R. Pohlmann, R.C.R. Beck, Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release and photostability, J. Nanosci. Nanotechnol. 10 (2010) 3091-3099.
36. E. Jäger, C.G. Venturini, F.S. Poletto, L.M. Colomé, J.P.U. Pohlmann, A. Bernardi, A.M.O. Battastini, S.S. Guterres, A.R. Pohlmann, J. Biomed. Nanotechnol. 5 (2009) 130-140.
37. E. Martini, E. CarvalhoH, Teixeira Adsorção de oligonucleotídeos em nanoemulsões obtidas por emulsificaç ão espontânea, Quim. Nova 30 (2007) 930-934.
38. M.C. Fontana, M.O. Bastos, R.C.R. Beck, Development and validation of a fast RP-HPLC method for the determination of clobetasol propionate in topical nanocapsule suspensions, J. Chromatogr. Sci. 48 (2010) 637-640.
39. M.J. Fresno Contreras, A.R. Diéguez, M.M. Jiménez Soriano, Rheological characterization of hydroalcoholic gels - 15% ethanol - of Carbopol Ultrez™ 10, Il Farmaco 56 (2001) 437-441.
40. M.K. Kim, S.Y. Choi, Evaluation of gender difference in skin type and pH, J. Dermatol. Sci. 41 (2006) 153-156.
41. G.S. Borghetti, M.T. Knorst, Desenvolvimento e avaliação da estabilidade física de loções O/A contendo filtros solares, Rev. Bras. Cienc. Farm. 42 (2006) 531-537. (Pubitemid 46492620)
42. F.-Q. Hu, H. Yuan, H.H. Zhang, M. Fang, Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization, Int. J. Pharm. 239 (2002) 121-128. (Pubitemid 34615801)
43. J. Siepmann, N.A. Peppas, Modeling of drug release from delivery systems based on hydroxypropylk methylcellulose (HPMC), Adv. Drug Deliv. Rev. 48 (2001) 139-157. (Pubitemid 32434400)
44. D. Quintanar-Guerrero, B.N. Zorraquín-Cornejo, A. Ganem-Rondero, E. Piñón-Segundo, M.G. Nava-Arzaluz, J.M. Cornejo-Bravo, Controlled release of model substances from pH-sensitive hydrogels, J. Mex. Chem. Soc. 52 (2008) 272-278.
45. L.M. Brum, L.S. Lopes, N.M. Martins, J.F. Rezer, D. Araújo, G.M. Barbosa, D.A. Ferrony, I. Roggia, L.S. Trevisan, M.P. Alves, D.B. Leal, Atividade da NTPDase de linfócitos na dermatite de contato antes e após tratamento com dexametasona nanoestruturada, Lat. Am. J. Pharm. 28 (2009) 876-884.
46. A. Böyum, Isolation of mononuclear cells and granulocytes from human blood, isolation on mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g, Scand, J. Clin. Lab. Invest. Suppl. 97 (1968) 77-89.
47. D.B.R. Leal, C.A. Streher, T.N. Neu, F.P. Bittencourt, C.A.M. Leal, J.E.P. Silva, V.M. Morsch, M.R.C. Schetinger, Characterization of NTPDase (NTPDase 1; ectoapyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes, Biochim. Biophys. Acta 1721 (2005) 9-15. (Pubitemid 40093507)
48. M.M.A. Bradford, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
49. R.P. Chhabra, J.F. Richardson, Non-newtonian Flow and Applied Rheology: Engineering Applications, second ed., 2008, pp. 5-12.
50. M.A.R. Martinez, J.L.-V. Gallardo, M.M. Benavides, J.D.G. Lópes-Duran, V.G. Lara, Rheological behavior of gel and meloxicam release, Int. J. Pharm. 333 (2007) 17-23. (Pubitemid 46283267)
51. R.C. Rowe, P.J. Sheskey, P.J. Weller, Pharmaceutical Excepients, Pharmaceutical Press, London, UK, 2001.
52. A. Garg, D. Aggarwal, S. Garg, A. Singla, Spreading of semisolid formulations, Pharm. Technol. 26 (2002) 84-105.
53. G.L. Flynn, P.S. Shah, S.N. Tenjarla, M. Corbo, D. DeMagistris, T.G. Feldman, T.J. Franz, D.R. Miran, D.M. Pearce, J.A. Sequeira, J. Swarbrick, J.C.T. Wang, A. Yacobi, J.L. Zatz, Assessment of value and applications of in vitro testing of topical dermatological drug products, Pharm. Res. 16 (1999) 1325-1330. (Pubitemid 29449367)
54. G. Soslau, D. Youngprapakorn, A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation, Biochim. Biophys. Acta 1355 (1997) 131-140. (Pubitemid 27064039)